PAVmed (PAVM) Assets (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.95% |
| Sep 30, 2025 | -13.27% |
| Jun 30, 2025 | -16.91% |
| Mar 31, 2025 | 72.29% |
| Jun 30, 2024 | 5.80% |
| Mar 31, 2024 | 12.49% |
| Dec 31, 2023 | -21.18% |
| Sep 30, 2023 | -21.73% |
| Jun 30, 2023 | -17.77% |
| Mar 31, 2023 | 20.94% |
| Dec 31, 2022 | -25.51% |
| Sep 30, 2022 | -12.11% |
| Jun 30, 2022 | -2.23% |
| Mar 31, 2022 | -3.04% |
| Dec 31, 2021 | 102.34% |
| Sep 30, 2021 | -9.26% |
| Jun 30, 2021 | -7.78% |
| Mar 31, 2021 | 159.73% |
| Dec 31, 2020 | 88.29% |
| Sep 30, 2020 | 18.26% |
| Jun 30, 2020 | -12.18% |
| Mar 31, 2020 | 39.70% |
| Dec 31, 2019 | 64.33% |
| Sep 30, 2019 | -37.60% |
| Jun 30, 2019 | 62.10% |
| Mar 31, 2019 | -48.74% |
| Dec 31, 2018 | -9.59% |
| Sep 30, 2018 | -16.36% |
| Jun 30, 2018 | 198.95% |
| Mar 31, 2018 | 129.25% |
| Dec 31, 2017 | -49.28% |
| Sep 30, 2017 | 1,327.38% |
| Jun 30, 2017 | -79.30% |
| Mar 31, 2017 | 25.70% |
| Dec 31, 2016 | -56.17% |
| Sep 30, 2016 | -37.01% |
| Jun 30, 2016 | 303.53% |
| Mar 31, 2016 | -35.65% |